It is also noteworthy that other pro-angiogenic factors such as bFGF, P1GF, and MCP-1 were indistinguishable across the disease groups, suggesting the pro-angiogenic effects of PsA and RA SFC are heterogeneous and act through different molecular pathways. Here, CCL2 is linked to rheumatoid arthritis.